The cost-benefit ratio of screening pregnant women for thrombophilia.

about

'To test or not to test', the arguments for and against thrombophilia testing in obstetrics.

P2860

Q38692085-7B363E5E-9FE6-41F7-A302-7072C88A9A5B

P2860

The cost-benefit ratio of screening pregnant women for thrombophilia.

Item

http://www.wikidata.org/entity/Q36969463

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

The cost-benefit ratio of screening pregnant women for thrombophilia.

@en

type

Item

label

The cost-benefit ratio of screening pregnant women for thrombophilia.

@en

prefLabel

The cost-benefit ratio of screening pregnant women for thrombophilia.

@en

P1476

The cost-benefit ratio of screening pregnant women for thrombophilia.

@en

P2093

Gian Cesare Guidi

http://www.w3.org/2001/XMLSchema#string

Giovanni Targher

http://www.w3.org/2001/XMLSchema#string

P2860

Activation of endothelial cell protease activated receptor 1 by the protein C pathway

Progress in the understanding of the protein C anticoagulant pathway

A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase

Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C

Hyperhomocysteinemia, atherosclerosis and thrombosis

Thrombophilia and severe preeclampsia: time to screen and treat in future pregnancies?

Thrombophilia: implications for pregnancy outcome

Thrombomodulin-protein C-EPCR system: integrated to regulate coagulation and inflammation

International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)

Deep vein thrombosis during enoxaparin prophylactic treatment in a young pregnant woman homozygous for factor V Leiden and heterozygous for the G127-->a mutation in the thrombomodulin gene.

P304

189-203

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2450/2007.0022-07

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2007-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23995196

http://www.w3.org/2001/XMLSchema#string

P698

19204775

http://www.w3.org/2001/XMLSchema#string

P921

thrombophilia

P932

2581909

http://www.w3.org/2001/XMLSchema#string

The cost-benefit ratio of screening pregnant women for thrombophilia.

about

P2860

P2860

The cost-benefit ratio of screening pregnant women for thrombophilia.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P921

P932